Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A zero due to an “invalid element” resulted in a much lower score than if Amber Glenn had simply fallen. Joosep Martinson / Getty Images MILAN — When Amber Glenn skated in the women’s short program at ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Ask anyone who owned or owns one, and they’ll tell you that Honda Element was ahead of its time, delivering a flexible interior, car-like ride, and SUV-levels of visibility – and, if Honda really ...

Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...

Many space-lovers know the phrase “We are all made of star stuff.” And it’s true — our planet formed from the dust cloud left over from the formation of our Sun, and from the planet, all life. That ...

View post: Walmart Is Selling a 'Speedy' and 'Reliable' $500 Electric Scooter for 46% Off It’s no secret that crossovers are unstoppably popular these days, regardless of how soulless and dreary many ...

Shrishty is a decade-old journalist covering a variety of beats between politics to pop culture, but movies are her first love, which led her to study Film and TV Development at UCLAx. She lives and ...

San Diego has been a powerhouse when it comes to genetic sequencing. But industry leader Illumina is being challenged by an eight-year-old startup, led by a woman who was once on Illumina’s payroll.

The Honda Element arrived onto the scene with the 2003 model year. This squared-off and somewhat retro-looking crossover was based upon the already hugely popular Honda CR-V platform, but it took an ...

Illumina is suing Element Biosciences, with the sequencing giant accusing its smaller rival of infringing on five of its patents covering flow cell and imaging technologies used in automated genetic ...